Additional considerations for prescribers and pharmacists Cost and reimbursement The superior efficacy of tirzepatide may justify higher cost for some patients
Whether you are on a lower dose that has stopped producing results or experiencing issues with your injection technique, dose-related factors deserve attention early in your troubleshooting process
Stopping rules: Discontinue GHK-Cu if free copper exceeds 25 mcg/dL, 24-hour urine copper exceeds 100 mcg/day, ALT or AST rises to more than 3 times the patient's baseline value, or clinical signs of copper toxicity appear
At Highland Longevity, every prescription is tracked with DEXA body composition scanning so you lose fat, not muscle
Semaglutide is currently the most prominent approved option in this class: Ozempic (semaglutide injection) licensed for type 2 diabetes management Wegovy (semaglutide 2.4 mg injection) licensed specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
A simple and effective strategy to invest in weight loss drugs is a weight loss ETF, such as the Tema GLP-1, Obesity and Cardiometabolic ETF (HRTS)